The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...

A recent study led by Paul DeCaen, Ph.D., associate professor of Pharmacology, has identified novel molecular mechanisms by ...

Techcyte is proud to share results from a published pilot study demonstrating the effectiveness of its AI-powered kidney ...

There are several renal syndromes that are unique to patients with cancer, being caused either by the cancer itself or by its treatment. This Review provides nephrologists—who are essential ...